trial · primary record
Ontunisertib
Fibrostenotic Crohn's Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 320 |
| Primary completion | 2029-06-30 |
| Primary endpoint | Proportion of participants achieving endoscopic passability of the ileal index stricture |
| Registry ID | NCT07683325 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:30.652Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07683325
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.